Effectness of Treatment With Mechanical Insufflation-Exsufflation

NCT ID: NCT04149873

Last Updated: 2019-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients defined with impaired cough function as maximum expiratory pressure (MEP) \< 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP \< 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endotracheal intubation and mechanical ventilation are always used to treat acute respiratory failure in critically ill patients. Successful weaning from ventilator and extubation are crucial to determine the prognosis when patient's underlying disease getting improvement. The reasons for extubation failure include lack of improvement of on the work of breathing, hypoxemia, respiratory acidosis, conscious disturbance and retained respiratory secretions, etc. In our clinical practice, the factor of retained respiratory secretions plays an important role in successful extubation.

Traditional chest physiotherapy (CPT) is commonly used to help the critically patients in the effective expulsion of airway secretions. In recent years, new advanced techniques mechanical insufflations-exsufflation (MI-E) and high frequency chest wall oscillation (HFCWO)have been developed to get more effective to remove secretions for patients suffered from acute respiratory failure. The above devices have been described as an effective techniques for patients with chronic neuromuscular weakness, cystic fibrosis and bronchiectasis. By the knowledge, only one study mentioned about MI-E could reduce the reintubation rate and shorten the ICU length of stay. But its limitations include less of case number and not focusing on impaired cough function patients.

In this study, patients defined with impaired cough function as maximum expiratory pressure (MEP) \< 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP \< 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mortality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Control group' has the treatment with \[Physical chest care \]

Group Type PLACEBO_COMPARATOR

MIE

Intervention Type PROCEDURE

MIE

Experimental group-A

'Experimental group-A' has the treatment with \[Mechanical-Insufflation- Exsufflation\]

Group Type PLACEBO_COMPARATOR

MIE

Intervention Type PROCEDURE

MIE

Experimental group-B

'Experimental group-B' has the treatment with \[Mechanical-Insufflation- Exsufflation\] and \[Physical chest care\]

Group Type EXPERIMENTAL

MIE

Intervention Type PROCEDURE

MIE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MIE

MIE

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Written Informed Consent given by the patient or, if not possible, by a legally authorized representative and/or an independent physician as authorized by the competent ethics committee (EC) or independent review board (IRB) and local regulations.
* 2.To be at least 20 years of age.
* 3.To be treated in an ICU at the time of enrollment.
* 4.Endotracheal tube in place
* 5.The patient is mechanically ventilated and reach:

1. Ventialtopr: Pressure support mode
2. reach 6-8CC/IBW, ideal body weight for 24 hours
3. MEP, maximum expiratory pressure \< 60cmH2O

Exclusion Criteria

* 1.The patient or legally authorized representative refuse
* 2.\< 20 years of age.
* 3.Neither endotracheal tube nor mechanical ventilator use
* 4.The patient is mechanically ventilated, but:

1. The ventialtopr mode NOT: Pressure support mode
2. No reach 6-8CC/IBW, ideal body weight for 24 hours
3. MEP, maximum expiratory pressure \> 60cmH2O
* 5.Participation as subject in another interventional study within 30 days prior to the first dose of study treatment, or planned participation in such a study during the study or within 30 days of its completion by the patient.
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chimei Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kuo-Chen Cheng

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kuo-Chen Cheng, Chief

Role: STUDY_CHAIR

Chi Mei Medical Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Intensive Care Medicine; Chi Mei Medical Center

Tainan City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMFHR 10460(IRB10407-008)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.